BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
See today's BioWorld
Home
» PTO Agrees To Re-Examine WARF Claims In Stem Cells
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
PTO Agrees To Re-Examine WARF Claims In Stem Cells
April 4, 2007
By
Randy Osborne
No Comments
As consumer advocates trumpeted their victory, others took a longer view of the U.S. Patent and Trademark Office's preliminary denial of claims in three stem cell patents held by the Wisconsin Alumni Research Foundation (WARF). (BioWorld Today)
BioWorld